2021 annual financial data
Immuneering 2021 Operating cash flow margin
Direct answer
Operating cash flow margin was -1,483.24%.
Operating income was -33,886,069 USD and net income was -33,535,748 USD.
Operating cash flow was -30,850,882 USD.
Get free Immuneering email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 2,079,961 USD
- Operating income
- -33,886,069 USD
- Net income
- -33,535,748 USD
- Operating cash flow
- -30,850,882 USD